¼¿ï¼º¸ðº´¿ø 2019³â Á¦28ȸ ´ëÇÑÀü¸³¼±ÇÐȸ Á¤±âÇмú´ëȸ : 2019-03-09±³À°ÀÏÀÚ : 2019-03-09
±³À°Àå¼Ò : ¼¿ï¼º¸ðº´¿ø ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ
±³À°ÁÖÁ¦ :
2019³â Á¦28ȸ ´ëÇÑÀü¸³¼±ÇÐȸ Á¤±âÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѺñ´¢±â°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀü¸³¼±ÇÐȸ
´ã´çÀÚ : ±è¹ÎÈñ
¿¬¶ôó : 031-987-5963
À̸ÞÀÏ :
gaonpco@gaonpco.com ±³À°Á¾·ù : ºñ´¢±â°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 09:00~09:50 Podium Session Á¶¹®±â(¿øÀڷº´¿ø)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 09:50~10:05 Update in Active Surveillance ±èº´ÈÆ(°è¸íÀÇ´ë)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 10:05~10:20 Role of Prebiopsy MRI ÀüȲ±Õ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 10:20~10:35 Clinical Utility of Prostate Health Index (phi) in Korea ±èÁ¤Çö(°¿øÀÇ´ë)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 10:35~10:50 Initial Experience of Focal High-Intensity Focused Ultrasound ÀÌÇйÎ(¼¿ïÀÇ´ë)
ÈÞ½Ä 03-09 ¸¶¸®¾ÆȦ 10:50~11:10 Coffee Break ()
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 11:10~11:30 Á¤³âÅðÀÓ ±â³äƯ° ±èõÀÏ(°è¸íÀÇ´ë)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 11:30~12:00 Biomarkers in Prostate Cancer Management Yves Fradet(Laval University Quebec Canada)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 12:00~12:15 Microbiota in Patients with CP/CPPS Á¤½ÂÀÏ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 12:15~12:30 Is CP/CPPS an Infectious Disease of the Prostate? Á¶ÀÎâ(±¹¸³°æÂûº´¿ø)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 12:30~12:50 Why Should We Consider BTAs (Bone Targeted Agents) for mCRPC? Á¤À翵(±¹¸³¾Ï¼¾ÅÍ)
½Ä»ç 03-09 ¸¶¸®¾ÆȦ 12:50~13:40 lunch ()
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 13:40~14:10 Treatment of Advanced Prostate Cancer: A Changing Algorithm Yves Fradet(Laval University Quebec Canada)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 14:10~14:25 Aquablation Therapy for BPH ½ÅÀ¯¼·(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 14:25~14:40 Current Update of BPH Surgery Á¶Á¤±â(ÇѾçÀÇ´ë)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 14:40~14:55 Male Incontinence: The Etiology or Basis of Treatment ±èÀçÇå(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 14:55~15:10 Male Underactive Bladder: Diagnosis and Surgical Treatment Options Á¶¼ºÅÂ(ÇѸ²ÀÇ´ë)
ÈÞ½Ä 03-09 ¸¶¸®¾ÆȦ 15:10~15:30 Coffee Break ()
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 15:30~16:20 Podium Session 2 ¹ÚÈ«¼®(°í·ÁÀÇ´ë)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 16:20~16:35 Evolving Treatment Paradigm of mCSPC ¹ÚÁ¾¿í(¿øÀڷº´¿ø)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 16:35~16:50 New Directions in Non-metastatic CRPC: Key Facet for Optimal Management ±è¼öµ¿(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 16:50~17:05 Is There Optimal Treatment Sequence for mCRPC? ÇÏÀ¯½Å(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03-09 ¸¶¸®¾ÆȦ 17:05~17:20 Does Immune Checkpoint Inhibitor Works in Prostate Cancer? ±è¼ºÇÑ(±¹¸³¾Ï¼¾ÅÍ)